STERIS logo

STERISNYSE: STE

Profile

Sector:

Healthcare

Country:

United States

IPO:

01 June 1992

Next earnings report:

01 August 2024

Last dividends:

12 June 2024

Next dividends:

N/A
$21.50 B
-15%vs. 3y high
96%vs. sector
-72%vs. 3y high
81%vs. sector
-11%vs. 3y high
75%vs. sector
-36%vs. 3y high
57%vs. sector

Price

after hours | Wed, 03 Jul 2024 17:04:23 GMT
$217.38-$0.96(-0.44%)
$1.12 B$1.29 B
$1.12 B-$1.38 M

Analysts recommendations

Institutional Ownership

STE Latest News

STERIS (STE) Gains From New Offerings, Macro Issues Ail
zacks.com17 June 2024 Sentiment: -

STERIS' (STE) AST successfully offers a wide range of sterilization modalities through a worldwide network of more than 50 contract sterilization and laboratory facilities.

Unlocking Steris (STE) International Revenues: Trends, Surprises, and Prospects
Zacks Investment Research13 May 2024 Sentiment: POSITIVE

Examine the shifting revenue streams from international markets for Steris (STE) and how this is influencing Wall Street's forecasts and the stock's potential.

Exploring Analyst Estimates for Steris (STE) Q4 Earnings, Beyond Revenue and EPS
Zacks Investment Research03 May 2024 Sentiment: POSITIVE

Gain a more thorough understanding of Steris' (STE) potential performance for the quarter ending in March 2024 by looking beyond Wall Street's revenue and profit forecasts and analyzing estimates for its important metrics.

Here's Why You Should Retain STERIS (STE) Stock for Now
Zacks Investment Research02 May 2024 Sentiment: POSITIVE

Investors can expect good results from STERIS' promising future in the healthcare and pharmaceutical sectors.

Here's Why Steris (STE) is Poised for a Turnaround After Losing -9.06% in 4 Weeks
Zacks Investment Research09 April 2024 Sentiment: POSITIVE

The intense selling pressure on Steris (STE) may have subsided as it is currently in oversold territory from a technical standpoint. Furthermore, the consensus among Wall Street analysts in raising earnings forecasts suggests that the stock is primed for a turnaround.

Here's Why Investors Should Retain STERIS (STE) Stock for Now
Zacks Investment Research28 March 2024 Sentiment: POSITIVE

Investors are optimistic about STERIS (STE) on strong Healthcare business performance and raised 2024 guidance.

Here's Why Investors Should Retain STERIS (STE) Stock for Now
Zacks Investment Research27 February 2024 Sentiment: POSITIVE

Investors are optimistic about STERIS (STE) on continuous recovery of healthcare procedures and upbeat 2024 guidance.

Why Steris (STE) is a Top Momentum Stock for the Long-Term
Zacks Investment Research15 February 2024 Sentiment: POSITIVE

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Steris (STE) is a Top Growth Stock for the Long-Term
Zacks Investment Research12 February 2024 Sentiment: POSITIVE

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

STERIS (STE) Q3 Earnings Top Estimates, Fiscal '24 Sales View Up
Zacks Investment Research08 February 2024 Sentiment: POSITIVE

STERIS' (STE) fiscal 2024 third-quarter results demonstrate the remarkable performance of the Healthcare segment.

  • 1(current)
  • 2

What type of business is STERIS?

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

What sector is STERIS in?

STERIS is in the Healthcare sector

What industry is STERIS in?

STERIS is in the Medical Devices industry

What country is STERIS from?

STERIS is headquartered in United States

When did STERIS go public?

STERIS initial public offering (IPO) was on 01 June 1992

What is STERIS website?

https://www.steris.com

Is STERIS in the S&P 500?

Yes, STERIS is included in the S&P 500 index

Is STERIS in the NASDAQ 100?

No, STERIS is not included in the NASDAQ 100 index

Is STERIS in the Dow Jones?

No, STERIS is not included in the Dow Jones index

When does STERIS report earnings?

The next expected earnings date for STERIS is 01 August 2024